Kips Bay Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 13   

Articles published

KIPS 0.390 +0.005 (1.33%)
price chart
Kips Bay Medical Provides Feasibility Study Update and Reports Second ...
Kips Bay Medical, Inc. is a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, the eSVS Mesh, for use in coronary artery bypass grafting surgery.
Related articles »  
Kips Bay Medical Receives Updated CE Mark Approval
Kips Bay Medical, Inc. (Nasdaq: KIPS), a medical device company focused on manufacturing and commercializing its external saphenous vein support technology, eSVS� Mesh, for use in coronary artery bypass grafting, or CABG, surgery, today announced ...
Kips Bay Medical (KIPS) Reports Updated CE Mark Approval  StreetInsider.com (subscription)
Related articles »  
Stock Runners : Silver Wheaton (NYSE:SLW), Yahoo (NASDAQ:YHOO), Kips ...
On 12 AUG Kips Bay Medical, Inc. (NASDAQ:KIPS) announced its earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter.
Related articles »  
Stock Highlights: Taylor Devices (NASDAQ:TAYD), Global Power Equipment ...
On 28 July 2014 Manny Villafana, Chairman and CEO of Kips Bay Medical Inc. (NASDAQ:KIPS), announced that on July 17, 2014, Lenox Hill Hospital in New York City performed its first implant of an eSVS(R) Mesh.
Traders Are Watching : FireEye, Inc. (NASDAQ:FEYE), Mondelez International ...
Kips Bay Medical (NASDAQ:KIPS) announced its earnings results on Tuesday. The company reported ($0.04) earnings per share (EPS) for the quarter.
Kips Bay Medical Inc receives updated CE Mark Approval